A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis

Archives of Dermatology

Volumn 144, Issue 6, 2008, Pages 774-778

  Billet, Sara E ^a   Kortuem, Kimberly R ^a   Gibson, Lawrence E ^a   El Azhary, Rokea ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; DAPSONE; ERTAPENEM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METHYLPREDNISOLONE SODIUM SUCCINATE; METRONIDAZOLE; TRIAMCINOLONE ACETATE; VANCOMYCIN;

ABSCESS DRAINAGE; ADULT; AGED; ANAMNESIS; ARTICLE; BACTERIUM CULTURE; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; CONSULTATION; DERMATITIS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LINEAR IGA BULLOUS DERMATOSIS; LIVER ABSCESS; MALE; MEASLES LIKE RASH; MICROSCOPY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME; WOUND INFECTION;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNITY; BIOPSY; COLECTOMY; DIAGNOSIS, DIFFERENTIAL; DIVERTICULITIS, COLONIC; DRUG ERUPTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; ILEOSTOMY; IMMUNOGLOBULIN A; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; SKIN; SKIN DISEASES, VESICULOBULLOUS; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 45349098196     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.6.774     Document Type: Article

References (14)

1. Neughebauer BI, Negron G, Pelton S, Plunkett RW, Beutner EH, Magnussen R. Bullous skin disease: an unusual allergic reaction to vancomycin. Am J Med Sci. 2002;323(5):273-278.
2. Onodera H, Mihm MC Jr, Yoshida A, Akasaka T. Drug-induced linear IgA bullous dermatosis. J Dermatol. 2005;32(9):759-764.
3. Nousari HC, Kimyai-Asadi A, Caeiro JP, Anhalt GJ. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin: report of 2 cases and review of the literature. Medicine (Baltimore). 1999; 78(1):1-8.
4. Jones DH, Todd M, Craig TJ. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome. J Am Osteopath Assoc. 2004;104(4):157-163.
5. Whitworth JM, Thomas I, Peltz SA, Sullivan BC, Wolf AH, Cytryn AS. Vancomycin-induced linear IgA bullous dermatosis (LABD). J Am Acad Dermatol. 1996; 34(5, pt 2):890-891.
6. Solky BA, Pincus L, Horan RF. Vancomycin-induced linear IgA bullous dermatosis: morphology is a key to diagnosis. Cutis. 2004;73(1):65-67.
7. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol. 1994;30(2, pt 1):187-192.
8. Herron MD, Zone JJ. Dermatitis herpetiformis and linear IgA bullous dermatosis. In: Bolognia JL, Jorizzo JL, Rapini RP, et al, eds. Dermatology. Vol 1. London, England: Mosby; 2003:479-489.
9. Carpenter S, Berg D, Sidhu-Malik N, Hall RP III, Rico MJ. Vancomycin-associated linear IgA dermatosis: a report of three cases. J Am Acad Dermatol. 1992;26(1):45-48.
10. Armstrong AW, Fazeli A, Yeh SW, Mackool BT, Liu V. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme. J Cutan Pathol. 2004; 31(5):393-397.
11. Waldman MA, Black DR, Callen JP. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol. 2004;29 (6):633-636.
12. Yawalkar N, Reimers A, Hari Y, et al. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatology. 1999;199(1):25-30.
13. Murray PD, McKenzie DT, Swain SL, Kagnoff MF. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol. 1987;139(8):2669-2674.
14. Palmer RA, Ogg G, Allen J, et al. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol. 2001;145(5):816-820.